pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,885 catalysts · 4,876 phase readout · 2,350 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 12 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: patent expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,350
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease7
    • Dermatology1
    • Oncology1

    Date TBD

    50
    ›COMPLETEDphase readoutNCT03049475: Pathophysiology of Acute Pain in Patients With Sickle Cell Disease

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Sickle Cell Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07035275: Effect of Patient-Anesthesiologist Gender Concordance and Analgesia Method on Postoperative Pain in Mastectomy Patients

    Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Breast Cancer, Mastectomy, Postoperative Pain, Analgesic Use

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06315075: Dialectical Behavior Therapy for Adolescents With Self-harm and Suicidal Behavior- an Open Trial

    Sponsor: Haukeland University Hospital. Phase: NA. Conditions: Self-harm, Suicidal Ideation, Suicide and Self-harm

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06633757: Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance

    Sponsor: ReCode Therapeutics. Phase: PHASE1. Conditions: Primary Ciliary Dyskinesia (PCD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07505212: Effects of Gallotannins on the Gut Microbiome and How it Affects Inflammatory Markers Among Obese Individuals.

    Sponsor: Prairie View A&M University. Phase: NA. Conditions: Obesity (Disorder)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05305781: Study of the Determinants of Emergency Dialysis in Reunion Island

    Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: . Conditions: Dialysis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07583381: A Prospective Study of a Subharmonic-Aided Pressure Estimate Technology for Early Prediction of Response to Systemic Therapy in Colorectal Cancer Liver Metastases

    Sponsor: The First Hospital of Jilin University. Phase: NA. Conditions: Colorectal Liver Metastasis, Liver Neoplasms, Colorectal Neoplasms

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06513065: Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)

    Sponsor: University of Southampton. Phase: PHASE3. Conditions: Pseudomyxoma Peritonei

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05868265: A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Urothelial Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05848765: Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy

    Sponsor: University of Birmingham. Phase: PHASE2. Conditions: Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06722365: Characterization of Fetal Lung With Quantitative Ultrasound

    Sponsor: University of Wisconsin, Madison. Phase: . Conditions: Respiratory Complication, Fetal Lung Imaging

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05780567: Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer

    Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE3. Conditions: Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04708067: Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Intrahepatic Cholangiocarcinoma AJCC v8

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07318467: Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone

    Sponsor: Cairo University. Phase: NA. Conditions: Post Partum Hemorrhage

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05666167: Expanding Exercise Programming for Veterans Through Telehealth

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Arthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07153367: Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)

    Sponsor: Centre Hospitalier Intercommunal Creteil. Phase: PHASE2. Conditions: Infertility, Insemination

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02682667: Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Multiple Myeloma, Lymphoma, Non-Hodgkin, Leukemia-Lymphoma, Adult T-Cell, Hodgkin Disease, Non-Small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07385300: Omega-3 Pufa and Aspirin as Adjunctive Therapy in Treatment of Smoker Patients With Stage Iii Periodontitis

    Sponsor: Alexandria University. Phase: NA. Conditions: Periodontitis, Diabete Mellitus

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07382700: Metabolic Characteristics of Plasma OxPLs in STEMI Patients.

    Sponsor: First Affiliated Hospital of Ningbo University. Phase: . Conditions: STEMI - ST-segment Elevation Myocardial Infarction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07326007: Verbal Analgesia Versus Standard Technique for Pain Control During Copper T380A Intrauterine Device Insertion in Women With Previous Cesarean Delivery

    Sponsor: Cairo University. Phase: NA. Conditions: Contraception

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00698607: Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing

    Sponsor: Seoul National University Hospital. Phase: PHASE4. Conditions: Coronary Artery Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07538492: Clinical Validation of an Artificial Intelligence-Based G-FAST Score in Patients With Stroke

    Sponsor: Xuanwu Hospital, Beijing. Phase: . Conditions: Stroke

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05034536: PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma

    Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Metastatic Melanoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06980636: A Trial of Shengmai Liquid for Long COVID Fatigue.

    Sponsor: Beijing University of Chinese Medicine. Phase: PHASE4. Conditions: Long COVID Fatigue

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06603311: Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection

    Sponsor: Hannover Medical School. Phase: NA. Conditions: Compensated Liver Disease (Disorder), Hepatitis D, Chronic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06043011: Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms

    Sponsor: iOMEDICO AG. Phase: . Conditions: Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), Waldenström's Macroglobulinemia (WM)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04204811: Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: NA. Conditions: Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Carcinoma, Fallopian Tube Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04943211: Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging

    Sponsor: Anna Raciborska. Phase: PHASE3. Conditions: Histiocytosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07228611: Assesment and Comparison of Osteoporosis Risk Factors After Stroke

    Sponsor: Ankara Etlik City Hospital. Phase: . Conditions: Stroke Osteoporosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07302971: Telemedicine-supported Management for Acute Ischemic Stroke

    Sponsor: Capital Medical University. Phase: NA. Conditions: Acute Ischemic Stroke

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06768671: An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

    Sponsor: MoonLake Immunotherapeutics AG. Phase: PHASE3. Conditions: Hidradenitis Suppurativa

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00185744: Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

    Sponsor: Stanford University. Phase: NA. Conditions: Breast Cancer, Carcinoma, Ductal

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07382544: Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Advanced Cancer, Solid Tumor

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07342244: Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

    Sponsor: Donghua Zhang. Phase: NA. Conditions: AML, AML (Acute Myeloid Leukemia)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07121244: A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

    Sponsor: Radionetics Oncology. Phase: PHASE1. Conditions: Locoregionally Recurrent Hormone-receptor Positive Breast Cancer, Metastatic Hormone Receptor Positive Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02346734: Physical Telerehabilitation in Veterans With Multiple Sclerosis

    Sponsor: University of Maryland, Baltimore. Phase: NA. Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03354234: Evaluation of the ORTHO-LBNP System

    Sponsor: Military Institute of Aviation Medicine. Phase: NA. Conditions: Orthostatic Hypotension, Ischemia, Hypoxia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01619709: Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage

    Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Intracerebral Hemorrhage

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04057664: A Group Therapy Based on the Bio-psycho-social Treatment Approach for Women With Chronic Pelvic and Chronic Belly Pain

    Sponsor: Swiss Paraplegic Research, Nottwil. Phase: . Conditions: Pain, Chronic, Pain, Pelvic, Pain, Abdominal, Depression, Sex Disorder, Endometriosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06282809: The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy

    Sponsor: HistoSonics, Inc.. Phase: NA. Conditions: Pancreas Cancer, Adenocarcinoma of the Pancreas, Pancreatic Cancer, Tumor of Pancreas

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07342309: Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States

    Sponsor: Boehringer Ingelheim. Phase: . Conditions: Metastatic Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07490899: Combined Nutrition and Parenting Study

    Sponsor: University of South Carolina. Phase: PHASE3. Conditions: Early Childhood Development (ECD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07119099: The relatıonshıp Between Upper Extremity Exercise Test and Exercise Capacity ın patıents wıth Idiopathic Pulmonary Fibrosis

    Sponsor: Marmara University. Phase: . Conditions: Idiopathic Pulmonary Fibrosis (IPF)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07260799: Clinical Performance of Capillary Blood Samples Collected Using the Tasso+ Serum Gel Capillary Blood Collection System for Clinical Chemistry Testing of 14 Analytes on an Abbott Alinity Analyzer

    Sponsor: Tasso Inc.. Phase: . Conditions: Serum Analytes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07244432: Post-ERCP Pancreatitis - Prophylactic Measures Implementation Study (PEP-PROMIS)

    Sponsor: Branislav Kuncak. Phase: . Conditions: Pancreatitis, Acute, ERCP, Prophylaxis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06299098: A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05030298: Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

    Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Malignant Glioma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04087798: Controlling Hypertension Through Education and Coaching in Kidney Disease

    Sponsor: University of Michigan. Phase: NA. Conditions: Chronic Kidney Diseases, Chronic Disease, Chronic Kidney Disease, Stage 3 (Moderate), Chronic Kidney Disease, Stage 4 (Severe), Chronic Kidney Disease Stage 5, Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07361263: Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency

    Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: AVP Deficiency, Diabetes Insipidus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07052487: Effectiveness of Post Isometric Relaxation Technique Versus Simple Stretching Exercises for Pain and Physical Activity in Young Females With Primary Dysmenorrhea in Peshawar

    Sponsor: Khyber Medical University Peshawar. Phase: NA. Conditions: Dysmenorrhea, Menstrual Pain

    full page →ctgov ↗
    ← prev
    page 35 of 98
    next →